Reviva Pharmaceuticals Holdings Return on Equity

The latest ROE for RVPH is -113901093.61%. That is below the Healthcare sector average of 29.33%. Investors often review this figure alongside Reviva Pharmaceuticals Holdings's historical trend and sector peers before judging valuation or financial health.

Against Healthcare companies, RVPH currently prints -113901093.61% for ROE, while the sector average sits near 29.33%. That is roughly 388327383.5% below the sector mean. Large gaps often invite a closer look at Reviva Pharmaceuticals Holdings's growth, margins, and balance sheet.

Return on Equity shows how effectively Reviva Pharmaceuticals Holdings converts resources into returns. At -113901093.61%, RVPH may look efficient or underperforming depending on peer benchmarks and trend direction. Pair the percentage with revenue growth and leverage for a fuller health check.

After noting RVPH's ROE (-113901093.61%), review year-over-year change, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.

This page's peer comparison chart is the fastest way to stack Reviva Pharmaceuticals Holdings's ROE against similar Healthcare names. You can also browse sector and industry screens on Stockcircle for a broader set of Healthcare companies and their key multiples and fundamentals.